文献速递类风湿关节炎

靶向光动力疗法选择性杀伤实验性关节炎中的活化成纤维细胞

Targeted photodynamic therapy selectively kills activated fibroblasts in experimental arthritis.
PubMed 文献 · Rheumatology (Oxford) · 2020-01-01

该研究基于抗FAP抗体28H1偶联光敏剂IRDye700DX构建靶向光动力疗法(tPDT),在体外验证其可高效诱导FAP特异性细胞死亡,在抗原诱导性关节炎小鼠中评估抗体分布不受偶联影响,并在胶原诱导性关节炎小鼠中观察到关节炎发展中度延迟,提示tPDT可能具有治疗(难治性)关节炎的潜力。

要点

  • 28H1-700DX在体外可高效诱导FAP特异性细胞死亡。
  • 偶联光敏剂不影响抗FAP抗体在关节炎膝关节的聚集。
  • FAP-tPDT在胶原诱导性关节炎小鼠中中度延迟关节炎发展。

核心结论

  • tPDT可在体外选择性靶向并杀伤FAP阳性成纤维细胞,并在RA小鼠模型中调节关节炎。

研究设计与样本

  • 研究将光敏剂IRDye700DX偶联至抗FAP抗体28H1,在体外用稳定转染FAP的3T3细胞系评估tPDT效率。
  • 在健康C57BL/6N小鼠及抗原诱导性关节炎C57BL/6N小鼠中评估[111In]In-DTPA-28H1(含或不含IRDye700DX)的生物分布。
  • 在抗原诱导性关节炎C57BL/6N小鼠注射偶联物24小时后,离体处理膝关节以评估FAP-tPDT诱导靶向损伤的潜力。
  • 在胶原诱导性关节炎小鼠中评估FAP-tPDT对关节炎发展的影响。

主要发现

  • 28H1-700DX在体外能高效诱导FAP特异性细胞死亡。
  • 偶联光敏剂未影响抗FAP抗体在关节炎膝关节中的聚集。
  • 在胶原诱导性关节炎小鼠中,FAP-tPDT后关节炎发展中度延迟。

临床怎么用

  • 该策略可能为难治性关节炎提供一种选择性清除FAP阳性活化成纤维细胞的治疗思路。

局限性

  • 研究仅基于小鼠模型和体外实验,尚未在人体中验证疗效与安全性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: In RA, synovial fibroblasts become activated. These cells express fibroblast activation protein (FAP) and contribute to the pathogenesis by producing cytokines, chemokines and proteases. Selective depletion in inflamed joints could therefore constitute a viable treatment option. To this end, we developed and tested a new therapeutic strategy based on the selective destruction of FAP-positive cells by targeted photodynamic therapy (tPDT) using the anti-FAP antibody 28H1 coupled to the photosensitizer IRDye700DX. METHODS: After conjugation of IRDye700DX to 28H1, the immunoreactive binding and specificity of the conjugate were determined. Subsequently, tPDT efficiency was established in vitro using a 3T3 cell line stably transfected with FAP. The biodistribution of [111In]In-DTPA-28H1 with and without IRDye700DX was assessed in healthy C57BL/6N mice and in C57BL/6N mice with antigen-induced arthritis. The potential of FAP-tPDT to induce targeted damage was determined ex vivo by treating knee joints from C57BL/6N mice with antigen-induced arthritis 24 h after injection of the conjugate. Finally, the effect of FAP-tPDT on arthritis development was determined in mice with collagen-induced arthritis. RESULTS: 28H1-700DX was able to efficiently induce FAP-specific cell death in vitro. Accumulation of the anti-FAP antibody in arthritic knee joints was not affected by conjugation with the photosensitizer. Arthritis development was moderately delayed in mice with collagen-induced arthritis after FAP-tPDT. CONCLUSION: Here we demonstrate the feasibility of tPDT to selectively target and kill FAP-positive fibroblasts in vitro and modulate arthritis in vivo using a mouse model of RA. This approach may have therapeutic potential in (refractory) arthritis.

来源:Rheumatology (Oxford),查看原文。版权归原作者所有。

引用

  1. Dorst DN, Rijpkema M, Boss M, et al. Targeted photodynamic therapy selectively kills activated fibroblasts in experimental arthritis. Rheumatology (Oxford). 2020. PMID: 32734285. doi:10.1093/rheumatology/keaa295

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。